Onderneming XOMA Corp Nasdaq
Aandelen
US98419J1079
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 6 | 100,0 % | 5 | 100,0 % | -21,06% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
76,9
%
| 4 | 74,3 % | 4 | 76,9 % | -18,29% |
Asia Pacific
23,1
%
| 2 | 25,7 % | 1 | 23,1 % | -29,03% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Owen Hughes
CEO | Chief Executive Officer | 49 | 01-01-23 |
Thomas Burns
DFI | Director of Finance/CFO | 50 | 14-08-06 |
Bradley Sitko
CIO | Chief Investment Officer | 43 | 03-01-23 |
Juliane Snowden
IRC | Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Heather Franklin
BRD | Director/Board Member | 58 | 06-08-21 |
Chairman | 68 | 26-08-10 | |
Joseph Limber
BRD | Director/Board Member | 71 | 12-12-12 |
Matthew Perry
BRD | Director/Board Member | 51 | 16-02-17 |
Barbara Kosacz
BRD | Director/Board Member | 66 | 01-01-19 |
Owen Hughes
CEO | Chief Executive Officer | 49 | 01-01-23 |
Natasha Hernday
BRD | Director/Board Member | 52 | 30-06-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 984 000 | 0 | 0 | 99,58 % |
Aandeel B | 1 | 11 635 015 | 11 587 438 ( 99,59 %) | 0 | |
Aandeel C | 0 | 1 600 | 0 | 0 |
Bedrijfsgegevens
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
+1,28% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-7,05% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |